Effectiveness of oxytocin intranasal on reducing alcohol consumption and depression syndrome in a patient with oropharyngeal carcinoma, a quasi-experimental single-case design structure

Phase 1

• Conditions: All the data of this study were collected after agreement with the patient, and informed consent was received before the intervention and publication, and all stages of the study were based on the lat; Oxytocin, Cancer oropharyngeal, Alcohol use disorder, Depression

• Registration Number: TCTR20180417001
• Lead Sponsor: none

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2015-05-01
• Study Start: 2018-04-17
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Terminated (Halted Prematurely)
• Sex: Male
• Target Recruitment: 1

Inclusion Criteria

single-case design structure

Exclusion Criteria

single-case design structure

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Alcohol consumption rate 14 months and 44 evaluations Alcohol Use Disorders Identification Test (AUDIT)

Secondary Outcome Measures

Name	Time	Method
depression index 14 months and 44 evaluations Beck Depression Inventory (BDI)